{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:45:02Z","timestamp":1783536302471,"version":"3.55.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cytogfr.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T12:05:36Z","timestamp":1625227536000},"page":"10-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"special_numbering":"C","title":["SARS-CoV-2 Mutations and their Viral Variants"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0359-6308","authenticated-orcid":false,"given":"Begum","family":"Cosar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Yagmur","family":"Karagulleoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Turan","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilruba Beyza","family":"Uncuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5892-5928","authenticated-orcid":false,"given":"Bugrahan Regaip","family":"Kilinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus Emre","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmet Ceyda","family":"Ozkoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Naki","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Eker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyzanur","family":"Karagoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said Yasin","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunyamin","family":"Yasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmetcan","family":"Pala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem Naz","family":"Atak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul Hanife","family":"Mendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahdi Umut","family":"Bengi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guldane","family":"Cengiz Seval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evrim","family":"Gunes Altuntas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-3069","authenticated-orcid":false,"given":"Pelin","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-2507","authenticated-orcid":false,"given":"Devrim","family":"Demir-Dora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2021.06.001_bib0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.25701","article-title":"Transmission dynamics and evolutionary history of 2019\u2010nCoV","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0010","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.jmb.2020.07.009","article-title":"Mutations strengthened SARS-CoV-2 infectivity","volume":"432","author":"Chen","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0015","article-title":"SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies The CITIID-NIHR BioResource COVID-19 Collaboration","author":"Collier","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","article-title":"The coding capacity of SARS-CoV-2","volume":"589","author":"Finkel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","article-title":"The architecture of SARS-CoV-2 transcriptome","volume":"181","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2020.04.002","article-title":"Genomics functional analysis and drug screening of SARS-CoV-2","author":"Chen","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008762","article-title":"COVID-19 pandemic: insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2","volume":"16","author":"Mittal","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2020.114032","article-title":"Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses","volume":"289","author":"Chen","year":"2021","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18683\/germs.2019.1155","article-title":"Middle east respiratory syndrome coronavirus (MERS-COV): a review","volume":"9","author":"Ramadan","year":"2019","journal-title":"GERMS"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0050","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/app11041497","article-title":"Comparison of selected characteristics of SARS-CoV-2, SARS-CoV, and HCoV-NL63","volume":"11","author":"Ba\u010denkov\u00e1","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12985-020-01401-2","article-title":"In vitro virucidal activity of Echinaforce\u00ae, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2","volume":"17","author":"Signer","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0060","series-title":"COVID-19 Evolves in Human Hosts","author":"Li","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/v11040328","article-title":"Canine respiratory coronavirus, bovine coronavirus, and human coronavirus OC43: receptors and attachment factors","volume":"11","author":"Szczepanski","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0070","doi-asserted-by":"crossref","first-page":"104285","DOI":"10.1016\/j.meegid.2020.104285","article-title":"Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species","volume":"82","author":"Li","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0075","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.79.2.884-895.2005","article-title":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia","volume":"79","author":"Woo","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0085","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3389\/fmicb.2020.02086","article-title":"Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature","volume":"11","author":"Schoeman","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0090","article-title":"Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses","author":"Hicks","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7234961","article-title":"Sequence analysis and structure prediction of SARS-CoV-2 accessory proteins 9b and ORF14: evolutionary analysis indicates close relatedness to bat coronavirus","author":"Baruah","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0100","series-title":"Ref. Modul. Life Sci","first-page":"428","article-title":"Human coronavirus-229E, -OC43, -NL63, and -HKU1","author":"Liu","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0105","doi-asserted-by":"crossref","first-page":"104490","DOI":"10.1016\/j.meegid.2020.104490","article-title":"Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2","volume":"89","author":"Kaur","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0110","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.coviro.2011.10.012","article-title":"SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission","volume":"1","author":"Bolles","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0115","series-title":"Ocular Infections View Project Zika Virus Vaccine Development View Project","author":"Rodriguez-Morales","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0130","series-title":"Adv. Virus Res","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","author":"Corman","year":"2018"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0135","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1371\/journal.pbio.0060226","article-title":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum","volume":"6","author":"Knoops","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.mib.2004.06.007","article-title":"Molecular biology of severe acute respiratory syndrome coronavirus","volume":"7","author":"Ziebuhr","year":"2004","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virusres.2006.01.017","article-title":"Nidovirales: Evolving the largest RNA virus genome","volume":"117","author":"Gorbalenya","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2217\/fvl-2018-0008","article-title":"Post-translational modifications of coronavirus proteins: roles and function","volume":"13","author":"Fung","year":"2018","journal-title":"Future Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0155","first-page":"1","article-title":"Role of host-mediated post-translational modifications (PTMS) in RNA virus pathogenesis","volume":"22","author":"Kumar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0160","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1099\/vir.0.19424-0","article-title":"Mechanisms and enzymes involved in SARS coronavirus genome expression","volume":"84","author":"Thiel","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0165","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1128\/JVI.78.24.13600-13612.2004","article-title":"Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity","volume":"78","author":"Harcourt","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0180","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0205","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/vaccines9010036","article-title":"SARS-CoV-2 spike protein elicits cell signaling in human host cells: implications for possible consequences of COVID-19 vaccines","volume":"9","author":"Suzuki","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0220","series-title":"S.A. 1#, B. Padmanabhan, Identification of a Potent Inhibitor Targeting the Spike Protein of Pandemic Human Coronavirus, SARS-CoV-2 by Computational Methods, ChemRxiv","author":"Unni","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0225","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0230","series-title":"A 193-amino-acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2 Downloaded From","author":"Wong","year":"2003"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0235","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1128\/JVI.02744-05","article-title":"Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0240","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0245","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0255","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/pathogens9050324","article-title":"Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment","volume":"9","author":"Koyama","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0260","article-title":"The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types","author":"Daniloski","year":"2020","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0265","first-page":"253","article-title":"Mutations observed in the SARS-CoV-2 spike glycoprotein and their effects in the interaction of virus with ACE-2 receptor","volume":"35","author":"Durmaz","year":"2020","journal-title":"Medeni. Med. J."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84053-8","article-title":"Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population","volume":"11","author":"Sixto-L\u00f3pez","year":"2021","journal-title":"Sci Rep ."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0275","first-page":"14","article-title":"Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant","volume":"13","author":"Yurkovetskiy","year":"2020","journal-title":"BioRxiv."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0280","unstructured":"D.J. Benton, A.G. Wrobel, C. Roustan, A. Borg, P. Xu, S.R. Martin, P.B. Rosenthal, J.J. Skehel, S.J. Gamblin, The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2, (n.d.). https:\/\/doi.org\/10.1073\/pnas.2022586118\/-\/DCSupplemental."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05116","article-title":"Characterization of local SARS-CoV-2 isolatesand pathogenicity in IFNAR\u2212\/- mice","volume":"6","author":"Hanifehnezhad","year":"2020","journal-title":"Heliyon."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0290","article-title":"Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study","author":"Sen","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.chom.2020.11.012","article-title":"D614G spike mutation increases SARS CoV-2 susceptibility to neutralization","volume":"29","author":"Weissman","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0300","article-title":"Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2","author":"Korber","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0305","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1128\/JVI.01394-09","article-title":"Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission","volume":"84","author":"Graham","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0310","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1007\/s00705-020-04830-0","article-title":"Identification of novel mutations in SARS-COV-2 isolates from Turkey","volume":"165","author":"Rehman","year":"2020","journal-title":"Arch. Virol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0315","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0320","series-title":"V483a-an Emerging Mutation Hotspot of Sars-Cov-2","author":"Ashwaq","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0325","series-title":"Spike Protein of SARS-CoV-2: Impact of Single Amino Acid Mutation and Effect of Drug Binding to the Variant-in Silico Analysis","author":"Manickavasagam","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0330","article-title":"Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus)","author":"Nguyen","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0335","article-title":"Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK","volume":"0","author":"Tang","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2021.01.025","article-title":"Introduction of Brazilian SARS-CoV-2 484K.V2 related variants into the UK","author":"Toovey","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0345","article-title":"Covid-19: the E484K mutation and the risks it poses","volume":"372","author":"Wise","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0350","article-title":"Distinct patterns of emergence of SARS-CoV-2 spike variants including N501Y in clinical samples in Columbus Ohio","author":"Tu","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0355","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding","volume":"182","author":"Starr","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0360","article-title":"Molecular mechanism of the N501Y mutation for enhanced binding between SARS-CoV-2\u2019s spike protein and human ACE2 receptor","author":"Luan","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies 1 by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"Elife."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0370","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.2088","article-title":"SARS-CoV-2 viral variants\u2014tackling a moving target","author":"Mascola","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0375","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0380","article-title":"Emergence and evolution of a prevalent new SARS-CoV-2 variant in the United States","author":"Pater","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0385","first-page":"52","article-title":"Genetic characteristics and phylogeny of 969-bp S gene sequence of SARS-CoV-2 from Hawai\u2019i reveals the worldwide emerging P681H mutation","volume":"80","author":"Maison","year":"2021","journal-title":"Hawai\u2019i J. Heal. Soc. Welf."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0390","article-title":"A unique SARS-CoV-2 spike protein P681H strain detected in Israel Israel National Consortium for SARS-CoV-2 sequencing","author":"Zuckerman","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0395","article-title":"Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India","author":"Cherian","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0400","article-title":"Bioinformatics analysis of SARS-CoV-2 RBD mutant variants and insights into antibody and ACE2 receptor binding","author":"Ranjan","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0405","doi-asserted-by":"crossref","first-page":"100086","DOI":"10.1016\/j.medidd.2021.100086","article-title":"The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant","volume":"10","author":"Ali","year":"2021","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0410","article-title":"Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2","volume":"11","author":"Singh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0415","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12967-020-02344-6","article-title":"Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant","volume":"18","author":"Pachetti","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0420","article-title":"Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States","author":"Washington","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0425","article-title":"Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: insights from linking epidemiological and genetic data","author":"Volz","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0430","doi-asserted-by":"crossref","first-page":"n230","DOI":"10.1136\/bmj.n230","article-title":"Covid-19: New UK variant may be linked to increased death rate, early data indicate","volume":"372","author":"Iacobucci","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0435","article-title":"Increased resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 to antibody neutralization","author":"Wang","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0440","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","author":"McCallum","year":"2021","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0445","doi-asserted-by":"crossref","DOI":"10.3201\/eid2704.210183","article-title":"Imported SARS-COV-2 variant P.1 detected in traveler returning from Brazil to Italy","volume":"27","author":"Maggi","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0450","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/pathogens10060633","article-title":"The emerging concern and interest SARS-CoV-2 variants","volume":"10","author":"Janik","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0455","article-title":"Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","author":"Garcia-Beltran","year":"2021","journal-title":"MedRxiv Prepr. Serv. Heal. Sci."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0460","article-title":"Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677","author":"Hodcroft","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0465","article-title":"A novel SARS-CoV-2 variant of concern, B.1.526, identified in New York","author":"Annavajhala","year":"2021","journal-title":"MedRxiv Prepr. Serv. Heal. Sci."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0470","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/v13061002","article-title":"The spike of concern\u2014the novel variants of SARS-CoV-2","volume":"13","author":"Winger","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0475","article-title":"Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York","author":"West","year":"2021","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0480","article-title":"Emergence of a novel SARS-CoV-2 strain in Southern California, USA","author":"Zhang","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0485","article-title":"Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein 1 triggers recent massive expansion of SARS-Cov-2 variants 2","author":"Tchesnokova","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0490","article-title":"Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427\/B.1.429 variant among healthcare personnel at a northern California academic medical center","author":"Jacobson","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0495","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/v13050751","article-title":"Within-host and between-host evolution in SARS-CoV-2\u2014new variant\u2019s source","volume":"13","author":"Moelling","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0500","article-title":"Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees","author":"Yadav","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0505","series-title":"Detection of New SARS-CoV-2 Variants Related to Mink","author":"Ecdc","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0510","doi-asserted-by":"crossref","first-page":"100536","DOI":"10.1016\/j.jbc.2021.100536","article-title":"The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization","volume":"296","author":"Bayarri-Olmos","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0515","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41577-021-00556-5","article-title":"Will SARS-CoV-2 variants of concern affect the promise of vaccines?","volume":"21","author":"Gupta","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0520","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0525","article-title":"Neutralization of SARS-CoV-2 spike 69\/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera","author":"Xie","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0530","first-page":"434059","article-title":"Structural Analysis of Spike Protein Mutations in the SARS-CoV-2 P. 3 Variant","author":"Andrew","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0535","unstructured":"Who, COVID-19 Weekly Epidemiological Update Global epidemiological situation, (n.d.)."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0540","article-title":"First identification of SARS-CoV-2 Lambda (C .37) variant in Southern Brazil","author":"Wink","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0545","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201312","article-title":"A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity","volume":"40","author":"Saha","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0550","article-title":"Infectivity and immune escape of the new SARS-CoV -2 variant of interest Lambda","author":"Acevedo","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0555","doi-asserted-by":"crossref","DOI":"10.1128\/MRA.00764-20","article-title":"Coding-complete genome sequences of three SARS-CoV-2 strains from Bangladesh","volume":"9","author":"Akter","year":"2020","journal-title":"Microbiol. Resour. Announc."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0560","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/pathogens9030240","article-title":"Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2","volume":"9","author":"ur Rehman","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0565","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/bib\/bbab042","article-title":"Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2","volume":"22","author":"Cheng","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0570","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/22221751.2020.1773745","article-title":"Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries","volume":"9","author":"Yang","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0575","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01800","article-title":"Geographic and Genomic Distribution of SARS-CoV-2 Mutations","volume":"11","author":"Mercatelli","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0580","doi-asserted-by":"crossref","first-page":"100925","DOI":"10.1016\/j.genrep.2020.100925","article-title":"Genetic variations among SARS-CoV-2 strains isolated in China","volume":"21","author":"Ahmed-Abakur","year":"2020","journal-title":"Gene Rep."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0585","doi-asserted-by":"crossref","first-page":"21","DOI":"10.24075\/brsmu.2020.045","article-title":"Spread of variants with gene N hot spot mutations in russian SARS-CoV-2 isolates","author":"Kiryanov","year":"2020","journal-title":"Bull. Russ. State Med. Univ."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0590","doi-asserted-by":"crossref","first-page":"e0238344","DOI":"10.1371\/journal.pone.0238344","article-title":"Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: an in silico insight","volume":"15","author":"Khan","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0595","series-title":"The United Kingdom\u2019s New Variant of COVID-19: What We Know and What We Don\u2019t Know, and What We Can Do to Respond to This Challenge","author":"Gerardo De Cosio","year":"2021"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0600","article-title":"Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa","author":"Tegally","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0605","article-title":"Patient-derived mutations impact pathogenicity of SARS-CoV-2","author":"Yao","year":"2020","journal-title":"SSRN Electron. J."},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0610","series-title":"Rasprostraneniye variantov s chastymi mutatsiyami v gene kapsidnogo belka N v rossiyskikh izolyatakh SARS-CoV-2, \u0412\u0435\u0441\u0442\u043d\u0438\u043a P\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0433\u043e \u0413\u043e\u0441\u0443\u0434\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e M\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0433\u043e \u0423\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442\u0430","first-page":"21","author":"\u041a\u0438\u0440\u044c\u044f\u043d\u043e\u0432","year":"2020"},{"key":"10.1016\/j.cytogfr.2021.06.001_bib0615","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5694\/mja2.50657","article-title":"Emerging viral mutants in Australia suggest RNA recombination event in the SARS-CoV-2 genome","volume":"213","author":"Yeh","year":"2020","journal-title":"Med. J. Aust."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:59:34Z","timestamp":1761217174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610121000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":123,"alternative-id":["S1359610121000538"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.06.001","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 Mutations and their Viral Variants","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}